Pacira Biosciences, Inc. (PCRX)
36.38
+0.04
(+0.11%)
USD |
NASDAQ |
Oct 20, 16:00
36.50
+0.12
(+0.33%)
After-Hours: 07:17
Pacira Biosciences Gross Profit (TTM) : 533.72M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 533.72M |
| March 31, 2026 | 525.72M |
| December 31, 2025 | 519.37M |
| September 30, 2025 | 510.17M |
| June 30, 2025 | 494.64M |
| March 31, 2025 | 488.17M |
| December 31, 2024 | 473.25M |
| September 30, 2024 | 459.44M |
| June 30, 2024 | 453.90M |
| March 31, 2024 | 441.40M |
| December 31, 2023 | 433.02M |
| September 30, 2023 | 409.51M |
| June 30, 2023 | 402.12M |
| March 31, 2023 | 399.64M |
| December 31, 2022 | 410.24M |
| September 30, 2022 | 427.06M |
| June 30, 2022 | 415.70M |
| March 31, 2022 | 409.61M |
| December 31, 2021 | 387.72M |
| September 30, 2021 | 368.90M |
| June 30, 2021 | 363.32M |
| March 31, 2021 | 316.18M |
| December 31, 2020 | 304.45M |
| September 30, 2020 | 299.30M |
| June 30, 2020 | 294.18M |
| Date | Value |
|---|---|
| March 31, 2020 | 318.58M |
| December 31, 2019 | 308.61M |
| September 30, 2019 | 291.19M |
| June 30, 2019 | 275.16M |
| March 31, 2019 | 262.72M |
| December 31, 2018 | 250.43M |
| September 30, 2018 | 237.08M |
| June 30, 2018 | 221.80M |
| March 31, 2018 | 205.74M |
| December 31, 2017 | 198.72M |
| September 30, 2017 | 190.21M |
| June 30, 2017 | 166.31M |
| March 31, 2017 | 165.77M |
| December 31, 2016 | 166.27M |
| September 30, 2016 | 166.88M |
| June 30, 2016 | 187.99M |
| March 31, 2016 | 181.62M |
| December 31, 2015 | 177.16M |
| September 30, 2015 | 170.09M |
| June 30, 2015 | 155.44M |
| March 31, 2015 | 142.43M |
| December 31, 2014 | 120.23M |
| September 30, 2014 | 92.59M |
| June 30, 2014 | 69.40M |
| March 31, 2014 | 49.12M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Viatris, Inc. | 5.838B |
| Johnson & Johnson | 68.45B |
| Liquidia Corp. | 416.18M |
| Organon & Co. | 3.253B |
| ANI Pharmaceuticals, Inc. | 505.18M |